Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 20 to 60

Art and learning support for parents of children with cancer

Official title: The Impact of Art Workshops and Cognitive Support on Enhancing Psychological Resilience Among Families of Children With Cancer.

Run by Children's Cancer Hospital Egypt 57357 · NCT07878078 · Data updated 2026-11-12

This trial tests whether a 3-month program of art workshops plus knowledge-based lectures helps reduce stress and build resilience in parents of children with cancer.

Quick facts

PhasePhase 3
Study typeInterventional
Ages20 Years to 60 Years
SexAll
Enrollment64 (estimated)
SponsorChildren's Cancer Hospital Egypt 57357
Academic / other
Locations1 site (Cairo, Cairo Governorate)
StatusRecruiting
StartedApril 27, 2026
Main results expectedJanuary 31, 2027
Study endsMarch 31, 2027
Registry record updatedOctober 16, 2026
Trial IDNCT07878078 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Parents (mother or father) of a child currently receiving cancer treatment, aged 20–60, who are willing to participate in all sessions.

Probably not a fit

Parents unable to commit to the full program or with active major psychiatric disorders may not experience benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional Phase 3 trial evaluates a combined program of art workshops and cognitive support lectures for parents of children undergoing cancer treatment. Participants are randomly assigned to receive the integrated program or standard care for 12 sessions over 3 months. The primary outcome is changes in psychological resilience among parents; the secondary analysis explores whether the child’s cancer type (solid vs hematological) affects the results. A total of 64 participants are enrolled, with 32 in each group, using block stratified randomization. The study is conducted at the Children's Cancer Hospital Egypt 57357 in Cairo.

Why it matters

Potential benefit: If successful, the program could provide a scalable approach to bolster parental resilience during a child’s cancer treatment.

How similar studies have gone: Similar psychosocial interventions for families have shown improvements in resilience, though this exact combined art and knowledge-based approach is relatively novel in this population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Parents (mother or father) of children with cancer currently undergoing treatment.
* Age between 20 and 60 years.
* Willingness to cooperate and participate in the program.
* Caregiver must be one of the parents

Exclusion Criteria:

* Cases with major depressive disorder, psychotic disorders (e.g., schizophrenia), bipolar disorder, recurrent panic disorder, or severe phobias.
* Parents unable to commit to attending sessions or following the program schedule.
* Cases with cognitive impairments or inability to communicate verbally.
* Families whose child is receiving palliative care.

Where it's running

  • Children's cancer hospital 57357
    Cairo, Cairo Governorate, Egypt
    Recruiting

Study contacts

  • Principal investigator: Amira Kaseem Elsahhar — Children's cancer hospital 57357
  • Study coordinator: Nancy Ashraf Abdellatif
  • Email: nancy.ashraf@57357.com
  • Phone: +201141083507

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.